APA (7th ed.) Citation

Miura, Y., Imai, H., Endo, S., Hashimoto, K., Yamaguchi, O., Mouri, A., . . . Kaira, K. (2026). Concurrent Chemoradiotherapy with Daily Low-Dose Carboplatin in Older Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer: Clinical Outcomes and Prognostic Significance of Systemic Inflammation Markers. Current Oncology, 31(3), 135. https://doi.org/10.3390/curroncol33030135

Chicago Style (17th ed.) Citation

Miura, Yu, et al. "Concurrent Chemoradiotherapy with Daily Low-Dose Carboplatin in Older Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer: Clinical Outcomes and Prognostic Significance of Systemic Inflammation Markers." Current Oncology 31, no. 3 (2026): 135. https://doi.org/10.3390/curroncol33030135.

MLA (9th ed.) Citation

Miura, Yu, et al. "Concurrent Chemoradiotherapy with Daily Low-Dose Carboplatin in Older Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer: Clinical Outcomes and Prognostic Significance of Systemic Inflammation Markers." Current Oncology, vol. 31, no. 3, 2026, p. 135, https://doi.org/10.3390/curroncol33030135.